Showing results (71-80 of 92) with videos related to
Sort By:
Pageof 10
Archives of Cardiovascular Diseases|December 22, 2022
Feasibility and accuracy of linking a heart failure registry to the national claims database using indirect identifiersDamien Logeart, Thibaud Damy, Maxime Doublet, et al.European Journal of Heart Failure|November 29, 2012
Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA studyDamien Logeart, Richard Isnard, Matthieu Resche-Rigon, et al.Archives of Cardiovascular Diseases|December 27, 2016
Patient journey in decompensated heart failure: An analysis in departments of cardiology and geriatrics in the Greater Paris University HospitalsFlorent Laveau, Nadjib Hammoudi, Emmanuelle Berthelot, et al.Basic Research in Cardiology|November 1, 2014
FHL2 expression and variants in hypertrophic cardiomyopathyFelix W Friedrich, Silke Reischmann, Aileen Schwalm, et al.Archives of Cardiovascular Diseases|April 21, 2024
Rationale and design of the PACIFIC-PRESERVED (PhenomApping, ClassIFication and Innovation for Cardiac dysfunction in patients with heart failure and PRESERVED left ventricular ejection fraction) studyJean-Sébastien Hulot, Philip Janiak, Philippe Boutinaud, et al.JACC. Heart Failure|April 28, 2023
Microbially Produced Imidazole Propionate Is Associated With Heart Failure and MortalityAntonio Molinaro, Ina Nemet, Pierre Bel Lassen, et al.Human Molecular Genetics|April 24, 2012
Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathyFelix W Friedrich, Brendan R Wilding, Silke Reischmann, et al.Orphanet Journal of Rare Diseases|June 10, 2025
Comparison of two genetic strategies for diagnostic work-up of hypertrophic cardiomyopathy: impact on the diagnosis of Fabry disease or transthyretin amyloidosisAurélien Palmyre, Fairouz Koraichi, Flavie Ader, et al.European Journal of Heart Failure|October 10, 2021
Early and short-term intensive management after discharge for patients hospitalized with acute heart failure: a randomized study (ECAD-HF)Damien Logeart, Emmannuelle Berthelot, Nicolas Bihry, et al.European Journal of Heart Failure|April 11, 2017
Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trialJean-Sébastien Hulot, Joe-Elie Salem, Alban Redheuil, et al.Pageof 10